Ondine Biomedical, Inc.LSE: OBI

Capital Access Window - Ondine Biomedical Inc.

· Investegate

NOTICE

30/09/2026 7:30am

AIM CAPITAL ACCESS WINDOW

ONDINE BIOMEDICAL INC.

At the request of the Company trading on AIM for the under-mentioned securities has been temporarily suspended pursuant to a Capital Access Window from 30/09/2026 7:30am, pending an announcement.

COMMON SHARES OF NO PAR VALUE, FULLY PAID (CDI)

(BNZGQK5) (CA68234M2058)

If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0)20 7409 3494.

Earlier from Ondine Biomedical

All Ondine Biomedical news releases